COVID-19 and Chronological Aging: Senolytics and Other Anti-aging Drugs for the Treatment or Prevention of Coronavirus Infection?

Published: April 6, 2020, 5 a.m.

b'SHR # 2497 :: Dr. Michael Lisanti, MD - PhD - The oldest in our global population have suffered the greatest mortality from this pandemic outbreak. Experts warn that this of us over 60 years of age are at greatest risk of dying. Many of us in this audience already use senolytic agents to help push back biological aging. Are these strategies helpful in protecting against COVID-19 as well? Is there a difference in the death toll of those who are chronological 0ver 60 years old versus a 65 year old person who is biologically 40? And what of time restricted feeding? It imparts some of the same benefits as senolytics. We learn the answers to these and more on today\\u2019s show. - Dr. David Nieman DRPH - Today\\u2019s interview discusses research discoveries within 4 areas of exercise immunology that have received the most attention from investigators: 1- acute and chronic effects of exercise on the immune system, 2- clinical benefits of the exercise\\u2013immune relationship, 3- nutritional influences on the immune response to exercise, and 4- the effect of exercise on immunosenescence.'